Skip to main content

Ultrasound Devices Market Global Opportunity, Demand by Applications, Share, Size and Treatment

Global Ultrasound Devices Market size is Expected to Reach USD 9,208.76 million by 2026, as per the latest findings of Market Research Future (MRFR). The development of 3D and 4D ultrasound imaging has allowed for the diagnosis of congenital defects clearly and earlier in the pregnancy, which has made the procedures widely popular in the healthcare sector around the world.
The growing demand for ultrasound devices for diagnostic purposes is likely to be the major driver for the global ultrasound devices market over the forecast period. Therapeutic applications of ultrasound include targeting a specific patch of tissue for stimulation or removal by bombarding it with high-frequency sound waves. This application is also likely to remain a key factor for the global ultrasound devices market’s growth over the forecast period.
The growing demand for more advanced ultrasound devices in the gynecology sector is likely to be a major driver for the global ultrasound devices market over the forecast period. 4D imaging also allows live action viewing of the fetus, which allows physicians to detect more abnormalities. This is likely to be a major driver for the global ultrasound devices market over the forecast period.
Competitive Analysis:
Some of the Leading key players in the global ultrasound devices market are likely to focus on bringing about steady technological innovation and updations in their products in the coming years, as developing more modern products has become a key selling point in the industry.  –
GE Healthcare
Hitachi Ltd.
Shimadzu Corporation
Analogic Corporation
Siemens AG
Mindray Medical International Ltd.
Toshiba Corporation
Samsung Electronics Co. Ltd.
Koninklijke Philips NV
and Others.
Global Ultrasound Devices Market Segmentation:
The global ultrasound devices market is segmented by application into diagnostic and therapeutic. The diagnostic application segment holds a dominant share of 68% in the global ultrasound devices market and is likely to remain the leading contributor over the forecast period.
Branch of Medicine:       Radiology, OB/GYN, Cardiac, And Others.
By Product Type:             Cart-Based and Portable.
By End User:                    Hospitals/Clinics and Ambulatory Care Centers.
Global Ultrasound Devices Market, by Application
  • Introduction
  • Radiology/General Imaging
  • Cardiology
  • Obstetrics/Gynecology
  • Anesthesiology
  • Urology
  • Vascular
  • Musculoskeletal
  • Gastroenterology
  • Neurology
Global Ultrasound Devices Market, by Technology
  • Introduction
  • Diagnostic Ultrasound
  • 2D Ultrasound
  • 3D And 4D Ultrasound
  • Doppler Ultrasound
  • Therapeutic Ultrasound
  • Extracorporeal Shockwave Lithotripsy (ESWL)
  • High-Intensity Focused Ultrasound (HIFU)
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...
Post a Comment
Read more

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...
Post a Comment
Read more

Nonallergic Rhinitis Market Data, Technology Treatment and Diagnosis Management Overview

  Nonallergic Rhinitis Market  Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023 Market Highlights Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential. Industry, Innovation & Related News November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal spra...
Post a Comment
Read more